MD Mednax Inc

Price (delayed)

$7

Market cap

$589.03M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.86

Enterprise value

$1.36B

Mednax, Inc. is a national medical group comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of Mednax are reshaping the delivery of ...

Highlights
The quick ratio has grown by 39% since the previous quarter and by 20% year-on-year
The debt has increased by 11% from the previous quarter but it has decreased by 5% YoY
The company's EPS has shrunk by 171% YoY and by 18% QoQ
The net income has dropped by 169% year-on-year and by 17% since the previous quarter

Key stats

What are the main financial stats of MD
Market
Shares outstanding
84.15M
Market cap
$589.03M
Enterprise value
$1.36B
Valuations
Price to book (P/B)
0.69
Price to sales (P/S)
0.29
EV/EBIT
N/A
EV/EBITDA
73.25
EV/Sales
0.68
Earnings
Revenue
$2B
EBIT
-$18.96M
EBITDA
$18.56M
Free cash flow
$81.36M
Per share
EPS
-$0.86
Free cash flow per share
$0.98
Book value per share
$10.18
Revenue per share
$24.12
TBVPS
$9.13
Balance sheet
Total assets
$2.17B
Total liabilities
$1.31B
Debt
$778.66M
Equity
$856.2M
Working capital
$179.24M
Liquidity
Debt to equity
0.91
Current ratio
1.72
Quick ratio
1.61
Net debt/EBITDA
41.52
Margins
EBITDA margin
0.9%
Gross margin
20.9%
Net margin
-3.5%
Operating margin
-0.3%
Efficiency
Return on assets
-3.1%
Return on equity
-7.8%
Return on invested capital
-1.6%
Return on capital employed
-1%
Return on sales
-0.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MD stock price

How has the Mednax stock price performed over time
Intraday
-5.41%
1 week
1.01%
1 month
-3.31%
1 year
-49.28%
YTD
-24.73%
QTD
-7.28%

Financial performance

How have Mednax's revenue and profit performed over time
Revenue
$2B
Gross profit
$418.39M
Operating income
-$6.83M
Net income
-$70.58M
Gross margin
20.9%
Net margin
-3.5%
MD's operating income has dropped by 193% since the previous quarter and by 104% year-on-year
The operating margin has dropped by 175% since the previous quarter and by 104% year-on-year
The net income has dropped by 169% year-on-year and by 17% since the previous quarter
The net margin has plunged by 169% YoY and by 17% from the previous quarter

Growth

What is Mednax's growth rate over time

Valuation

What is Mednax stock price valuation
P/E
N/A
P/B
0.69
P/S
0.29
EV/EBIT
N/A
EV/EBITDA
73.25
EV/Sales
0.68
The company's EPS has shrunk by 171% YoY and by 18% QoQ
The P/B is 59% below the 5-year quarterly average of 1.8 and 34% below the last 4 quarters average of 1.1
The equity is down by 6% YoY
The stock's price to sales (P/S) is 66% less than its 5-year quarterly average of 0.9 and 38% less than its last 4 quarters average of 0.5

Efficiency

How efficient is Mednax business performance
The company's return on sales has shrunk by 200% QoQ and by 110% YoY
The ROA has plunged by 172% YoY and by 19% from the previous quarter
MD's return on equity has dropped by 167% year-on-year and by 18% since the previous quarter
The ROIC has plunged by 112% YoY

Dividends

What is MD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MD.

Financial health

How did Mednax financials performed over time
The total assets is 65% greater than the total liabilities
The quick ratio has grown by 39% since the previous quarter and by 20% year-on-year
The company's current ratio rose by 39% QoQ and by 19% YoY
The debt is 9% less than the equity
The debt has increased by 11% from the previous quarter but it has decreased by 5% YoY
MD's debt to equity is up by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.